Company Filing History:
Years Active: 2020
Title: Dori Pelled: Innovator in Rett Syndrome Treatment
Introduction
Dori Pelled is a notable inventor based in Hod-Hasharon, Israel. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of Rett syndrome. His innovative work has the potential to impact the lives of many affected by this condition.
Latest Patents
Dori Pelled holds a patent for the use of aminoglycoside analogs in the treatment of Rett syndrome. The patent details compounds, methods, and uses of pseudo-trisaccharide aminoglycosides represented by a specific general formula. This invention aims to provide new therapeutic options for individuals suffering from Rett syndrome.
Career Highlights
Throughout his career, Dori Pelled has been associated with Eloxx Pharmaceuticals Ltd., where he has contributed to the development of groundbreaking treatments. His expertise in pharmaceutical sciences has positioned him as a key figure in the industry.
Collaborations
Dori Pelled has worked alongside talented colleagues such as Timor Baasov and Shmuel Tuvia. Their collaborative efforts have further advanced the research and development of innovative treatments in the pharmaceutical sector.
Conclusion
Dori Pelled's work exemplifies the spirit of innovation in the medical field. His contributions to the treatment of Rett syndrome highlight the importance of research and development in improving patient outcomes.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.